 |
Moderna has awarded its global corporate PR duties to DXTRA Health, a collective of more than 1,500 staffers housed within Interpublic shops.
A cross-disciplined group from Weber Shandwick, Golin and Jack Health will work to bolster the corporate reputation of the COVID-19 vaccine maker and spotlight its research savvy.
DXTRA Health “will further educate the world about Moderna’s mRNA technology and its promise to transform the future of human health,” said Kate Cronin, the company’s chief brand officer.
She told O’Dwyer’s that Moderna was not working with IPG prior to the June 13 DXTRA Health announcement.
“We used FTI for corporate global media relations and Ruder Finn for disease awareness work,” said Cronin, who headed Ogilvy Health before joining Moderna a year ago.
Laura Schoen, DXTRA Health’s chief healthcare officer, will lead the team that will support Moderna’s outreach to employees, policymakers, healthcare providers, vaccine recipients and consumers.
To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
